- Home
- RDVT vs ZVRA Comparison
RDVT vs ZVRA Comparison
Compare RDVT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDVT
- ZVRA
- Stock Information
- Founded
- RDVT 2017
- ZVRA 2006
- Country
- RDVT United States
- ZVRA United States
- Employees
- RDVT N/A
- ZVRA N/A
- Industry
- RDVT Computer Software: Prepackaged Software
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- RDVT Technology
- ZVRA Health Care
- Exchange
- RDVT Nasdaq
- ZVRA Nasdaq
- Market Cap
- RDVT 396.7M
- ZVRA 443.6M
- IPO Year
- RDVT N/A
- ZVRA 2015
- Fundamental
- Price
- RDVT $35.08
- ZVRA $8.96
- Analyst Decision
- RDVT Strong Buy
- ZVRA Strong Buy
- Analyst Count
- RDVT 1
- ZVRA 7
- Target Price
- RDVT $25.00
- ZVRA $21.00
- AVG Volume (30 Days)
- RDVT 54.0K
- ZVRA 513.4K
- Earning Date
- RDVT 11-06-2024
- ZVRA 11-12-2024
- Dividend Yield
- RDVT N/A
- ZVRA N/A
- EPS Growth
- RDVT N/A
- ZVRA N/A
- EPS
- RDVT 0.36
- ZVRA N/A
- Revenue
- RDVT $70,685,000.00
- ZVRA $23,689,000.00
- Revenue This Year
- RDVT $22.61
- ZVRA N/A
- Revenue Next Year
- RDVT $12.66
- ZVRA $318.48
- P/E Ratio
- RDVT $97.46
- ZVRA N/A
- Revenue Growth
- RDVT 21.43
- ZVRA 43.21
- 52 Week Low
- RDVT $16.56
- ZVRA $3.89
- 52 Week High
- RDVT $35.43
- ZVRA $9.02
- Technical
- Relative Strength Index (RSI)
- RDVT 78.09
- ZVRA 60.34
- Support Level
- RDVT $29.35
- ZVRA $7.67
- Resistance Level
- RDVT $30.54
- ZVRA $8.91
- Average True Range (ATR)
- RDVT 1.11
- ZVRA 0.36
- MACD
- RDVT 0.49
- ZVRA 0.03
- Stochastic Oscillator
- RDVT 90.97
- ZVRA 83.87
About RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in big data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses, and assets.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.